A Phase III Double-Blind Comparative Study of Pro-NETU in Patients Receiving Highly Emetogenic Chemotherapy (Cisplatin): CONSOLE
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008592/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a multicenter, randomized, double-blind, phase 3 study to evaluate the efficacy and safety of fosnetupitant (FosNTP) versus fosaprepitant (FosAPR) for preventing highly emetogenic chemotherapy-induced nausea and vomiting.
For more information, visit:
https://ascopubs.org/doi/full/10.1200/JCO.21.01315
提供机构：
Vivli
创建时间：
2022-11-18
